Novocure gets FDA nod for tumor-treating electric fields targeting pancreatic cancer Read more →
Gilead's latest synthetic lethal therapy comes via $1.5B deal with China's Genhouse Read more →
Biopharma funding to experience 'continued, albeit disciplined' recovery in 2026: PitchBook Read more →
